Table 1.
Baseline | 0.5 h | 1 h | 2 h | |
---|---|---|---|---|
Control | 25.61 ± 0.57 | 26.84 ± 1.30 | 27.88 ± 1.68 | 27.83 ± 1.50 |
LPS | 25.61 ± 0.57 | 27.43 ± 0.88 | 25.33 ± 1.2 | 24.58 ± 1.20 |
Rolipram+LPS | 25.61 ± 0.57 | 27.08 ± 2.03 | 31.38 ± 1.47 | 22.9 ± 1.0* |
Roflumilast+LPS | 25.61 ± 0.57 | 24.27 ± 0.66 | 28.07 ± 1.66 | 28.44 ± 1.11 |
PD-4-I treatment showed no consistent effect on microvascular vessels;
P < 0.05 vs. control.